Kole Roybal, PhDAssociate Professor, Microbiology & Immunology at UCSF School of MedicineSpeaker
Dr. Roybal is an Associate Professor in the Department of Microbiology and Immunology at the University of California, San Francisco. His lab has focused on the development of advanced engineered receptor systems (e.g. synNotch, SNIPRs, and CARs) that allow for the precise detection of tumors and the customization of the therapeutic response specifically at the site of disease. His mission is to engineer and distribute a comprehensive toolkit of clinically optimized molecular parts including new receptors and therapeutic signaling circuits that can be deployed in a broad range of cell-based therapeutics for diseases such as cancer and autoimmunity.
He was awarded the Sartorius and Science Magazine Prize for Regenerative Medicine and Cell Therapy in 2017, the NIH New Innovator Award in 2018, and the Cancer Research Institute STAR Award in 2022.He has also founded next-generation cell therapy companies based on his body of work including Cell Design Labs (now a Gilead company), Arsenal Bio, Dispatch Therapeutics, and Moonlight Bio.